Krisztina B Szanto,1,2 Jiawei Li,2,3 Paul Cordero,2 Jude A Oben2,4 1Faculty of Life Sciences and Medicine, School of Medicine, King’s College London, London, UK; 2Institute for Liver and Digestive Health, University College London, London, UK; 3Institute of Child Health, University College London, London, UK; 4Department of Gastroenterology and Hepatology, Guy’s and St Thomas’ Hospital, NHS Foundation Trust, London, UK Abstract: Obesity is the most prevalent noncommunicable disease in the 21st century, associated with triglyceride deposition in hepatocytes leading to nonalcoholic fatty liver disease (NAFLD). NAFLD is now present in around a third of the world’s population. Epidemiological studies have concluded that ...
Background/Objective: Nonalcoholic fatty liver disease affects 30% of the world adult population. It...
Non-alcoholic fatty liver disease (NAFLD) is spreading worldwide, with a racial/ethnic disparity. We...
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease which includes simple steatosis, ...
Obesity is the most prevalent noncommunicable disease in the 21st century, associated with triglycer...
Non-alcoholic fatty liver disease (NAFLD) is a significant public health concern worldwide with a co...
Nonalcoholic fatty liver disease (NAFLD) is a progressive condition that includes steatosis (NAFL) a...
Nonalcoholic fatty liver disease (NAFLD) is a progressive condition that includes steatosis (NAFL) a...
NAFLD is characterized by accumulation of fat in the liver that can lead to health complications. Pr...
Background: Non-alcoholic fatty liver disease (NAFLD) is a clinical syndrome predicted to be the nex...
Non-alcoholic fatty liver disease (NAFLD) comprehends a wide range of conditions, encompassing from ...
Objective—To characterize the prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) by race in a n...
Non-alcoholic fatty liver disease (NAFLD) was shown to disproportionally affect Hispanic persons. We...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/99594/1/hep26440.pd
BACKGROUND AND AIMS: Racial/ethnic disparities have been reported in the prevalence of nonalcoholic ...
BACKGROUND: Liver disease is a major cause of morbidity and mortality worldwide. Large numbers of li...
Background/Objective: Nonalcoholic fatty liver disease affects 30% of the world adult population. It...
Non-alcoholic fatty liver disease (NAFLD) is spreading worldwide, with a racial/ethnic disparity. We...
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease which includes simple steatosis, ...
Obesity is the most prevalent noncommunicable disease in the 21st century, associated with triglycer...
Non-alcoholic fatty liver disease (NAFLD) is a significant public health concern worldwide with a co...
Nonalcoholic fatty liver disease (NAFLD) is a progressive condition that includes steatosis (NAFL) a...
Nonalcoholic fatty liver disease (NAFLD) is a progressive condition that includes steatosis (NAFL) a...
NAFLD is characterized by accumulation of fat in the liver that can lead to health complications. Pr...
Background: Non-alcoholic fatty liver disease (NAFLD) is a clinical syndrome predicted to be the nex...
Non-alcoholic fatty liver disease (NAFLD) comprehends a wide range of conditions, encompassing from ...
Objective—To characterize the prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) by race in a n...
Non-alcoholic fatty liver disease (NAFLD) was shown to disproportionally affect Hispanic persons. We...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/99594/1/hep26440.pd
BACKGROUND AND AIMS: Racial/ethnic disparities have been reported in the prevalence of nonalcoholic ...
BACKGROUND: Liver disease is a major cause of morbidity and mortality worldwide. Large numbers of li...
Background/Objective: Nonalcoholic fatty liver disease affects 30% of the world adult population. It...
Non-alcoholic fatty liver disease (NAFLD) is spreading worldwide, with a racial/ethnic disparity. We...
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease which includes simple steatosis, ...